Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

GOSSAMER BIO, INC. (GOSS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

GOSSAMER BIO, INC. (GOSS), most recent 12 months reported: revenue $53.29M, net loss $125.22M, free cash flow -$162.63M. Latest balance sheet on file: liquid cash $57.03M, total debt $36.15M, net cash $20.88M. From SEC filings. Others in Pharmaceutical Preparations: Aquestive Therapeutics, Inc. · Tango Therapeutics, Inc. · Q32 Bio Inc. · Siga Technologies INC · OCULAR THERAPEUTIX, INC · Spero Therapeutics, Inc. · Biofrontera Inc. · INTEGRATED BIOPHARMA INC

Stock screener

Watchlist